AKRO - Akero Therapeutics GAAP EPS of -$0.90 beats by $0.05
2024-05-10 07:22:21 ET
More on Akero Therapeutics
- Akero Therapeutics' EFX Data Warrants Caution
- Akero: Phase 2b NASH Data Bodes Well For Phase 3 SYNCHRONY Program
- Akero Therapeutics announces pricing of stock offering to raise $319M
- Akero stock jumps as lead drug shows added fibrosis improvement in MASH patients
- Seeking Alpha’s Quant Rating on Akero Therapeutics